Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC

Primary Objective: To estimate the number of cancers in people with HIV (PWH) who present for care at domestic AMC sites Secondary Objectives: To characterize participants that are eligible but not enrolled onto AMC clinical trials to understand site-specific and trial-specific accrual barriers Exploratory Objectives: 1. To standardize and expand the quantity and quality of sociodemographic and cancer diagnostic and treatment characteristics collected for PWH receiving care at domestic AMC sites. 2. To describe cancer patient health-related QOL for PWH at domestic AMC sites using validated tools: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire \[EORTC QLQ-C30\] and Supportive Care Needs Survey Short Form 34 \[SCNS-SF34\] Outline: Participants identified via screening of electronic medical records or institutional databases. All eligible participants attend one visit for the collection of broad demographic and clinical data. Participants initiating or receiving ongoing treatment for their cancer will attend a single follow-up visit. Data collection at study visits will occur via survey procedures and/or medical record review.